April 12, 2022

GILBERT, Ariz., April 12, 2022— As part of CooperVision Specialty EyeCare’s commitment to providing eye care professionals (ECPs) with resources they need to succeed, the company has announced a new exchange policy and manufacturing guarantees for customers in the U.S. and Canada. These enhancements will improve both the ECP and patient experience.

The new exchange policy offers unlimited, no-charge exchanges on the company’s scleral contact lenses for up to 90 days, helping to remove the pressure of addressing harder-to-fit patients. In addition, Paragon CRT® and Dual Axis contact lenses are now guaranteed to be shipped in 72 hours or less to customers in the U.S.  For an additional $10 fee (added to the applicable product price), all CooperVision Specialty EyeCare lens orders can be produced and ready to ship within 24 hours.

“CooperVision Specialty EyeCare’s commitment to improving the industry goes beyond simply providing ECPs with an unmatched portfolio of advanced lenses. We are truly invested in their success,” said Tony Sommer, General Manager, CooperVision Specialty EyeCare, Americas. “The sector is evolving to give patients even better experiences, and we’re always evolving how we do business as well.”

For additional information about the company’s products, please visit CooperVisionSpecialtyEyeCare.com.

CooperVision Specialty EyeCare develops, manufactures, and provides access to a portfolio of industry leading soft custom and rigid gas permeable lens designs, including orthokeratology and scleral lenses to address segments such as myopia management, irregular cornea management and presbyopia management. Its steady voice, ongoing research and innovative products and services play a leading role in expanding care worldwide. The group’s brands include Blanchard, GP Specialists, Paragon, Procornea, Soflex, and No7 Contact Lenses.


# # #


About CooperVision
CooperVision, a division of CooperCompanies (NYSE:COO), is one of the world’s leading manufacturers of contact lenses. The company produces a full array of daily disposable, two-week and monthly soft contact lenses that feature advanced materials and optics, and premium rigid gas permeable lenses for orthokeratology and scleral designs. CooperVision has a strong heritage of addressing the toughest vision challenges such as astigmatism, presbyopia, childhood myopia, and highly irregular corneas; and offers the most complete portfolio of spherical, toric and multifocal products available. Through a combination of innovative products and focused practitioner support, the company brings a refreshing perspective to the marketplace, creating real advantages for customers and wearers. For more information, visit www.coopervision.com.

About CooperCompanies
CooperCompanies ("Cooper") is a global medical device company publicly traded on the NYSE (NYSE:COO). Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to developing a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical is committed to advancing the health of women, babies and families with its diversified portfolio of products and services focusing on medical devices and fertility & genomics. Headquartered in San Ramon, Calif., Cooper has a workforce of more than 12,000 with products sold in over 100 countries. For more information, please visit www.coopercos.com

Media Contact
Maggie Munley, Counselor, McDougall Communications
maggie@mcdougallpr.com or +1-585-434-2149